Bayer/Cellectis extend gene editing pact
Bayer CropScience and French genomics company Cellectis' US subsidiary, Cellectis Plant Sciences (New Brighton, Minnesota), have agreed two new deals covering gene editing in plants. The partnership seeks to create commercial traits for the canola seed market using new technologies developed by Cellectis, and provide Bayer with access to technologies that enable the directed engineering of plant genomes, such as gene stacking and targeted mutagenesis, for the development of improved crops. The agreements extend the companies' existing partnership to introduce targeted modifications to selected plant genes and genomes. The companies signed a deal giving Bayer access to Cellectis' meganuclease technology in 2012 (Agrow No 632, p 20). That extended a collaboration that began in 2006 (Agrow No 499, p 5).